Suchergebnisse - "Saab, Sammy"

PubPharm (14)

1

Meeting the WHO hepatitis C virus elimination goal : Review of treatment in paediatrics

enthalten in: Journal of viral hepatitis | 2020

von Kim, N. | Kullar, R. | Khalil, H. | +1

2

Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL

enthalten in: Digestive diseases and sciences | 2018

von Yanny, B. | Saab, S. | Durazo, F. | +6

3

Risk of Hepatitis B Virus Reactivation Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection

enthalten in: Journal of clinical gastroenterology | 2018

von Yanny, B. | Latt, N. | Saab, S. | +4

4

Treatment of Patients With Hepatitis C Virus Infection With Ledipasvir-Sofosbuvir in the Liver Transplant Setting

enthalten in: Transplantation | 2017

von Abaalkhail, F. | Elsiesy, H. | Elbeshbeshy, H. | +10

5

The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1 : Are the new all-oral regimens good value to society?

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2017

von Younossi, Z. | Park, H. | Dieterich, D. | +3

6

Treating Medicaid patients with hepatitis C : clinical and economic impact

enthalten in: The American journal of managed care | 2017

von Younossi, Z. | Gordon, S. | Ahmed, A. | +3

7

Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis

enthalten in: Journal of clinical gastroenterology | 2017

von Saab, S. | A Jimenez, M. | N Bau, S. | +5

8

Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US

enthalten in: Journal of medical economics | 2016

von Saab, S. | Parisé, H. | Virabhak, S. | +5

9

Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States

enthalten in: Advances in therapy | 2016

von Saab, S. | Virabhak, S. | Parisé, H. | +5

10

Real-world outcomes of ledipasvir/sofosbuvir in treatment-naive patients with hepatitis C

enthalten in: The American journal of managed care | 2016

von Younossi, Z. | Park, H. | Gordon, S. | +4